High Blood Pressure/Hypertension Drugs Monitoring and Device Market
Global High Blood Pressure/Hypertension Drugs and Monitoring Device Market Size, Share & Trends Analysis Report by Drugs (Pulmonary Hypertension Drugs and Systemic Hypertension Drugs), by Monitoring Devices (Aneroid Sphygmomanometers, Mercury Sphygmomanometer, Digital Devices, and Ambulatory BP Monitors), By End-User (Hospitals and Clinics and Homecare) and Forecast Period 2021-2027 Update Available - Forecast 2024-2030
The global high blood pressure/hypertension drugs and monitoring device market is growing at a considerable CAGR of 5.8% during the forecast period (2021-2027). Hypertension is one of the major causes of fatalities across the globe and occurs due to resistance in the blood flow caused by narrowed arteries. The major factors that are augmenting the growth of the market include the increasing prevalence of chronic diseases and the rising geriatric population across the globe. Aging is associated with a high risk of two events including physiological decline and disease state. The geriatric population in developing economies such as Indonesia, Bangladesh, and Thailand is higher than that in the developed countries. As per a report published by United Nations in 2018, the global population in the age group of 60 years and above is projected to increase from 901 million in 2018 to 1.4 billion by 2030. Moreover, there is a positive correlation between elderly individuals and an increase in the incidence of cardiovascular issues such as hypertension. As per the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7), hypertension occurs in more than two-thirds of individuals in the age group of 65 years and above. An increase in the elderly population constantly increases the burden on healthcare systems globally due to the high prevalence of hypertension and other associated disorders, which could accelerate the growth of the market.
Furthermore, obesity due to consumption of junk food along with rising consumption of alcohol is some of the other factors stimulating the growth of the market. However, certain factors that are affecting the growth of the market include lack of awareness in developing economies, inadequate healthcare infrastructure in underdeveloped countries and the declining average selling price for retailers and manufacturers could hinder the growth of the market during the forecast period. Conversely, the global targets set to reduce the prevalence of hypertension could be perceived as an opportunity for the market players. In addition, increasing healthcare expenditures and technological advancements are also fueling the market growth.
Segmental Outlook
The global high blood pressure/hypertension drugs and monitoring device market is segmented based on drugs, monitoring devices, and end-user. By drugs, the market is segmented into pulmonary hypertension drugs and systemic hypertension drugs. Based on the monitoring devices segment, the market is segmented into aneroid sphygmomanometers, mercury sphygmomanometer, digital devices, and ambulatory BP monitors. Based on the end-user segment, the market is bifurcated into hospitals and clinics, and home care.
Global High Blood Pressure/Hypertension Drugs and Monitoring Device Market Share by Monitoring Devices, 2020 (%)
The aneroid sphygmomanometers segment holds a major market share in 2020. The segment growth is driven by innovations in aneroid technologies and the affordability of aneroid monitors. The apparatus is compact and convenient to use for patients at home. However, aneroid sphygmomanometers have been seen to be less accurate when compared to mercury sphygmomanometers, which could restrain the growth of the segment. The aneroid sphygmomanometers kits providers include Omron Healthcare, Inc., American Diagnostic Corp., Rossmax International Ltd., Hill-Rom Holdings, Inc., and Withings.
Regional Outlooks
The global high blood pressure/hypertension drugs and monitoring device market is analyzed based on the geographical regions that are contributing significantly towards the growth of the market. Based on geography, the market is evaluated into North America, Europe, Asia-Pacific, and the Rest of the World. North America is estimated to be the leading region in the market. Developed healthcare infrastructure and the rising geriatric population are the major factors driving the growth of the market in North America. While Asia-Pacific is estimated to be the fastest-growing region during the forecast period. Large population base along with increasing chronic diseases, rise in awareness among people, and increasing investments by manufacturers are some of the factors that are estimated to fuel the market growth in the Asia-Pacific. According to the reports of the European Society of Cardiology, in 2018, one in every five young adults in India reported high blood pressure. The rising number of undiagnosed cases of high blood pressure will result in an increased need for blood pressure monitoring devices, which will benefit the market growth.
Global High Blood Pressure/Hypertension Drugs and Monitoring Device Market Growth, by Region 2021-2027
Market Players Outlook
Key players of the high blood pressure/hypertension drugs and monitoring device market are Hill-Rom Holdings, Inc., American Diagnostic Corporation, Boehringer Ingelheim International GmbH, Bayer AG, Koninklijke Philips N.V., GE Healthcare, Smiths Group plc, Omron Healthcare, Inc., among more. To survive in the market, these players adopt different marketing strategies such as mergers and acquisitions, product launches, geographical expansion, among more. For instance, in February 2021, Hill-Rom Holdings, Inc., announced the acquisition of contact-free continuous monitoring technology from EarlySense. The acquisition reportedly amounted to $30 million intended to expand Hillrom’s acute care settings business.
The Report Covers
- Market value data analysis of 2020 and forecast to 2027.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global high blood pressure/hypertension drugs and monitoring device market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Hypertension Drugs and Monitoring Device Market
• Recovery Scenario of Global Hypertension Drugs and Monitoring Device Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Regulations
3. Competitive Landscape
3.1. Key Strategy Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on Key Players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Hypertension Drugs and Monitoring Device Industry by Drugs
5.1.1. Diuretics
5.1.2. ACE Inhibitors
5.1.3. Calcium Channel Blockers
5.1.4. Beta-adrenergic Blockers
5.1.5. Vasodilators
5.1.6. Others
5.2. Global Hypertension Drugs and Monitoring Device Industry by Monitoring Devices
5.2.1. Aneroid Sphygmomanometers
5.2.2. Mercury Sphygmomanometer
5.2.3. Digital Devices
5.2.4. Ambulatory BP Monitors
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. South Korea
6.3.5. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. A & D Company, Ltd.
7.2. American Diagnostic Corp.
7.3. Boehringer Ingelheim International GmbH.
7.4. CONTEC MEDICAL SYSTEMS CO., LTD
7.5. Eli Lilly and Company
7.6. Hanmi Pharm.Co., Ltd.
7.7. Hill-Rom Holdings, Inc.
7.8. Koninklijke Philips N.V.
7.9. Medtronic plc
7.10. Merck & Co., Inc.
7.11. Microlife Corp.
7.12. Novartis International AG
7.13. Omron Healthcare, Inc.
7.14. Reata Pharmaceuticals, Inc.
7.15. Rossmax International Ltd.
7.16. Sanofi S.A.
7.17. SCHILLER AG
7.18. Smiths Group plc.
7.19. SunTech Medical, Inc.
7.20. Takeda Pharmaceutical Co. Ltd.
7.21. Withings
1. GLOBAL HYPERTENSION DRUGS AND MONITORING DEVICE MARKET RESEARCH AND ANALYSIS,2020-2027 ($ MILLION)
2. GLOBAL HYPERTENSION DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027($ MILLION)
3. GLOBAL DIURETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
4. GLOBAL ACE INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
5. GLOBAL CALCIUM CHANNEL BLOCKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
6. GLOBAL BETA-ADRENERGIC BLOCKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
7. GLOBAL VASODILATORS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
8. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
9. GLOBAL HYPERTENSION MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027($ MILLION)
10. GLOBAL ANEROID SPHYGMOMANOMETERS MARKET BY REGION, 2020-2027($ MILLION)
11. GLOBAL MERCURY SPHYGMOMANOMETERS MARKET BY REGION, 2020-2027($ MILLION)
12. GLOBAL DIGITAL DEVICES MARKET BY REGION, 2020-2027($ MILLION)
13. GLOBAL AMBULATORY BP MONITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
14. NORTH AMERICAN HIGH BLOOD PRESSURE/HYPERTENSION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
15. NORTH AMERICAN HIGH BLOOD PRESSURE/HYPERTENSION MARKET RESEARCH AND ANALYSIS BY DRUGS, 2020-2027($ MILLION)
16. NORTH AMERICAN HIGH BLOOD PRESSURE/HYPERTENSION MARKET RESEARCH AND ANALYSIS BY MONITORING DEVICES, 2020-2027($ MILLION)
17. EUROPEAN HIGH BLOOD PRESSURE/HYPERTENSION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
18. EUROPE HIGH BLOOD PRESSURE/HYPERTENSION MARKET RESEARCH AND ANALYSIS BY DRUGS, 2020-2027($ MILLION)
19. EUROPEAN HIGH BLOOD PRESSURE/HYPERTENSION MARKET RESEARCH AND ANALYSIS BY MONITORING DEVICES, 2020-2027($ MILLION)
20. ASIA-PACIFIC HIGH BLOOD PRESSURE/HYPERTENSION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
21. ASIA-PACIFIC HIGH BLOOD PRESSURE/HYPERTENSION MARKET RESEARCH AND ANALYSIS BY DRUGS, 2020-2027($ MILLION)
22. ASIA-PACIFIC HIGH BLOOD PRESSURE/HYPERTENSION MARKET RESEARCH AND ANALYSIS BY MONITORING DEVICES, 2020-2027($ MILLION)
23. REST OF THE WORLD HIGH BLOOD PRESSURE/HYPERTENSION MARKET RESEARCH AND ANALYSIS BY DRUGS, 2020-2027($ MILLION)
24. REST OF THE WORLD HIGH BLOOD PRESSURE/HYPERTENSION MARKET RESEARCH AND ANALYSIS BY MONITORING DEVICES, 2020-2027($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL HIGH BLOOD PRESSURE/HYPERTENSION MARKET, 2020-2027 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL HIGH BLOOD PRESSURE/HYPERTENSION MARKET BY SEGMENT, 2020-2027 ($ MILLION)
3. RECOVERY OF GLOBAL HIGH BLOOD PRESSURE/HYPERTENSION MARKET, 2021-2027 (%)
4. GLOBAL HIGH BLOOD PRESSURE/HYPERTENSION MARKET SHARE BY DRUGS, 2020 VS 2027(%)
5. GLOBAL HIGH BLOOD PRESSURE/HYPERTENSION MARKET SHARE BY MONITORING DEVICES, 2020 VS 2027(%)
6. GLOBAL HIGH BLOOD PRESSURE/HYPERTENSION MARKET SHARE BY END USER, 2020 VS 2027(%)
7. GLOBAL PULMONARY HYPERTENSION DRUGS MARKET BY REGION, 2020 VS 2027 (%)
8. GLOBAL SYSTEMIC HYPERTENSION DRUGS MARKET BY REGION, 2020 VS 2027 (%)
9. GLOBAL ANEROID SPHYGMOMANOMETERS MARKET BY REGION, 2020 VS 2027 (%)
10. GLOBAL MERCURY SPHYGMOMANOMETER MARKET BY REGION, 2020 VS 2027 (%)
11. GLOBAL DIGITAL DEVICES MARKET BY REGION, 2020 VS 2027 (%)
12. GLOBAL AMBULATORY BP MONITORS MARKET BY REGION, 2020 VS 2027 (%)
13. GLOBAL HOSPITALS AND CLINICS MARKET BY REGION, 2020 VS 2027 (%)
14. GLOBAL HOMECARE MARKET BY REGION, 2020 VS 2027 (%)
15. US HIGH BLOOD PRESSURE/HYPERTENSION MARKET SIZE, 2020-2027($MILLION)
16. CANADA HIGH BLOOD PRESSURE/HYPERTENSION MARKET SIZE, 2020-2027($MILLION)
17. UK HIGH BLOOD PRESSURE/HYPERTENSION MARKET SIZE, 2020-2027($MILLION)
18. FRANCE HIGH BLOOD PRESSURE/HYPERTENSION MARKET SIZE, 2020-2027($MILLION)
19. GERMANY HIGH BLOOD PRESSURE/HYPERTENSION MARKET SIZE, 2020-2027($MILLION)
20. ITALY HIGH BLOOD PRESSURE/HYPERTENSION MARKET SIZE, 2020-2027($MILLION)
21. SPAIN HIGH BLOOD PRESSURE/HYPERTENSION MARKET SIZE, 2020-2027($MILLION)
22. ROE HIGH BLOOD PRESSURE/HYPERTENSION MARKET SIZE, 2020-2027($MILLION)
23. INDIA HIGH BLOOD PRESSURE/HYPERTENSION MARKET SIZE, 2020-2027($MILLION)
24. CHINA HIGH BLOOD PRESSURE/HYPERTENSION MARKET SIZE, 2020-2027($MILLION)
25. JAPAN HIGH BLOOD PRESSURE/HYPERTENSION MARKET SIZE, 2020-2027($MILLION)
26. SOUTH KOREA HIGH BLOOD PRESSURE/HYPERTENSION MARKET SIZE, 2020-2027($MILLION)
27. REST OF ASIA-PACIFIC HIGH BLOOD PRESSURE/HYPERTENSION MARKET SIZE, 2020-2027($MILLION)
28. REST OF THE WORLD HIGH BLOOD PRESSURE/HYPERTENSION MARKET SIZE, 2020-2027($MILLION)
